Anticoagulation Decision in a Patient with Atrial Fibrillation and Falls
An 82-year-old woman with permanent atrial fibrillation, hypertension, and diabetes has a CHA2DS2-VASc score of 5 and a HAS-BLED score of 3. She lives alone and has had two mechanical falls in the past year without serious injury. She is currently on apixaban 5 mg twice daily. Her daughter is concerned about bleeding risk and asks whether the anticoagulant should be stopped. The patient is cognitively intact and wants to remain independent.
1. How would you address the daughter's concern about bleeding risk versus stroke risk?
Read the worked answer
The decision to anticoagulate should be based on the balance of stroke versus bleeding risk. Her CHA2DS2-VASc score of 5 confers a high annual stroke risk (approximately 6.7% per year), while the HAS-BLED score of 3 indicates a high bleeding risk but is not a reason to withhold anticoagulation. Falls are a risk factor for bleeding, but the absolute risk of subdural hematoma from a fall is low compared to the stroke risk. Anticoagulation with apixaban (a DOAC with lower intracranial hemorrhage risk than warfarin) is appropriate. Address modifiable bleeding risk factors: review medications (e.g., NSAIDs, antiplatelets), manage hypertension, and assess fall risk (vision, gait, home safety). Do not discontinue anticoagulation solely due to falls; instead, implement fall prevention strategies.
2. What specific interventions would you recommend to reduce her bleeding risk while maintaining stroke prophylaxis?
Read the worked answer
- Continue apixaban but consider dose reduction if criteria are met (age ≥80, weight ≤60 kg, creatinine ≥1.5 mg/dL) – currently she is on 5 mg BID, which is appropriate if she does not meet two of these criteria. 2. Fall prevention: home safety evaluation, physical therapy for gait and balance, vision check, and review of medications that increase fall risk (sedatives, antihypertensives). 3. Avoid NSAIDs and antiplatelets unless absolutely necessary. 4. Monitor renal function annually and adjust dose if needed. 5. Educate patient and family on signs of bleeding and when to seek help. 6. Consider referral to geriatrics for comprehensive fall risk assessment. 7. Reassess HAS-BLED score periodically and address modifiable factors.